J Physiol 1902;28:325-53.ArticlePubMedPMC 3
Arbutin is generally considered safe and has no known significant drug interactions
Importantly, hemodynamic effects - modest reductions in heart rate (+2-4 bpm) and blood pressure decreases - are generally well tolerated and beneficial in this population
Key points to consider when interpreting the evidence: Most studies are short-term , typically lasting fewer than 12 weeks, making it difficult to assess long-term efficacy or safety Results appear more pronounced in older adults or individuals with obesity, compared to younger, healthy populations L-carnitine alone, without dietary or lifestyle changes , is unlikely to produce clinically meaningful weight loss Neither NICE nor the NHS recommends L-carnitine supplementation as part of any weight management pathway
Strict Safety Protocols We follow high clinical standards, careful screening, and professional administration protocols designed to prioritize patient safety
Participants had an average age of about 65 years and were followed for up to three years after initiating treatment